SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-21-016637
Filing Date
2021-12-09
Accepted
2021-12-09 16:03:11
Documents
60
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q trda-20210930x10q.htm   iXBRL 10-Q 2148221
2 EX-31.1 trda-20210930xex31d1.htm EX-31.1 17478
3 EX-31.2 trda-20210930xex31d2.htm EX-31.2 17472
4 EX-32.1 trda-20210930xex32d1.htm EX-32.1 14188
  Complete submission text file 0001558370-21-016637.txt   6317971

Data Files

Seq Description Document Type Size
5 EX-101.SCH trda-20210930.xsd EX-101.SCH 35108
6 EX-101.CAL trda-20210930_cal.xml EX-101.CAL 28366
7 EX-101.DEF trda-20210930_def.xml EX-101.DEF 148716
8 EX-101.LAB trda-20210930_lab.xml EX-101.LAB 324733
9 EX-101.PRE trda-20210930_pre.xml EX-101.PRE 272380
10 EXTRACTED XBRL INSTANCE DOCUMENT trda-20210930x10q_htm.xml XML 890233
Mailing Address 6 TIDE STREET BOSTON MA 02210
Business Address 6 TIDE STREET BOSTON MA 02210 857-305-1825
Entrada Therapeutics, Inc. (Filer) CIK: 0001689375 (see all company filings)

IRS No.: 813983399 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40969 | Film No.: 211481959
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences